HALO logo
halo search icon
Bone Biologics Corp.

US$1.23

Price Change Indicator
-0.03 (-2.381%)
Bone Biologics Corp.
BBLG · NAS

Bone Biologics Corp.

Start Trading BBLG for Free

US$1.23

Price Arrow-0.03 (-2.381%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Bone Biologics Corp. Overview

BBLG Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BBLG

icon

Website

Bone Biologics Corp.

icon

Telephone

1.781.552.4452

icon

Address

Suite 100, 2 Burlington Woods Drive, Burlington, MA 01803

Description

Bone Biologics Corp. operates as a medical device company. It engages in the research and development of bone regeneration in spinal fusion. The firm's core product is NELL-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

BBLG Price Chart

Key Stats

Market Cap

US$2.26M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.05 - 6.75

Trade Value (12mth)

US$539,843.00

1 week

-0.79%

1 month

-9.68%

YTD

-18.18%

1 year

-76.96%

All time high

212400.00

Key Fundamentals

EPS 3 yr Growth

-98.60%

EBITDA Margin

0.00%

Operating Cashflow

-$3m

Free Cash Flow Return

-60.70%

ROIC

-70.20%

Interest Coverage

0.00

Quick Ratio

13.80

Other Data

Shares Outstanding (Fully Diluted)

2m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BBLG Announcements

Latest Announcements

DateAnnouncements
20 June 24
22 February 24
20 November 23
31 March 23
16 March 22

BBLG Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-204.05-28.97-2.65locklocklock
EPS (Fully Diluted)
 $locklocklocklock-204.05-28.97-2.65locklocklock
Growth
 %locklocklocklock-985.890.9locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Bone Biologics Corp. (BBLG:NAS)?
Halo FAQ
The current share price of Bone Biologics Corp. (BBLG:NAS) is USD$1.23.
What is the 52-week high share price for Bone Biologics Corp. (BBLG:NAS)?
Halo FAQ
The 52-week high share price for Bone Biologics Corp. (BBLG:NAS) is USD$6.75.
What is the 52-week low share price for Bone Biologics Corp. (BBLG:NAS)?
Halo FAQ
The 52-week low share price for Bone Biologics Corp. (BBLG:NAS) is USD$1.05.
What is the dividend yield for Bone Biologics Corp. (BBLG:NAS)?
Halo FAQ
Bone Biologics Corp. (BBLG:NAS) does not pay a dividend.
What was Bone Biologics Corp. (BBLG:NAS) last dividend payment?
Halo FAQ
Bone Biologics Corp. (BBLG:NAS) does not pay a dividend.
What is the franking level for Bone Biologics Corp. (BBLG:NAS)?
Halo FAQ
Bone Biologics Corp. (BBLG:NAS) has a franking level of 0.00%.
In which sector is Bone Biologics Corp. (BBLG:NAS) classified?
Halo FAQ
Bone Biologics Corp. (BBLG:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial